Observational Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Sep 6, 2020; 8(17): 3786-3796
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3786
Figure 1
Figure 1 Flow chart of the study. FMT: Fecal microbiota transplantation; TET: Transendoscopic enteral tubing.
Figure 2
Figure 2 Approaches to learn about fecal microbiota transplantation and transendoscopic enteral tubing for the first time. A, B: All respondents’ approaches to primarily knowing about fecal microbiota transplantation (A) and transendoscopic enteral tubing (B) in patients without experience of fecal microbiota transplantation.
Figure 3
Figure 3 Reasons for supporting fecal microbiota transplantation (A) and not supporting fecal microbiota transplantation (B).
Figure 4
Figure 4 Optimal methods of undergoing fecal microbiota transplantation. A: The preferred delivery of Crohn’s disease patients with and without experience of fecal microbiota transplantation; B: The preferred delivery way of ulcerative colitis patients with and without experience of fecal microbiota transplantation. FMT: Fecal microbiota transplantation; TET: Transendoscopic enteral tubing.